What Orreco does

Orreco (legal entity Orreco Limited, incorporated in Ireland) is a sports science intelligence platform founded in 2010 by Dr Brian Moore and Dr Andrew Hodgson in Galway, Ireland. The company sells a modular AI-driven performance stack — anchored by the Te@m web platform, the @thlete mobile app (v2.0 with Gen AI launched August 2024) and the FitrWoman/FitrCoach women's performance sub-brands — to elite professional sports teams (NBA, NFL, MLB, NHL, EPL, F1, PGA Tour), Olympic federations (USWNT, English Women's national team, Swiss FA, FAI, USA Swimming, The FA) and marquee endurance organisations (INEOS Britannia, Club Brugge, Ettifaq Club, Newcastle United). Modules include Biomarkers (point-of-care and venous testing), Motion Signal (computer-vision movement analysis), Medical Notes, Recovery Lab, Analytics & Reporting (B.A.R.I.), Wellness, Travel, Tr@ce (return-to-performance) and Tr*AI*n (training-load prediction), with deployments spanning 145+ countries.

The platform is built on a proprietary Bayesian inference engine embedded in an agentic AI architecture, with adaptive personalised reference ranges for each athlete and multimodal ingestion of biomarkers, GPS/external load, neuromuscular function, sleep/autonomic data, video, medical imaging, and free-text notes. Orreco claims an 85% sensitivity / 86% specificity non-contact soft-tissue injury risk model and a 400+ peer-reviewed publication base, supported by 19 PhDs on staff across haematology, biomarker science, computational intelligence, biostatistics and exercise immunology. Recent acquisitions (DDSA in December 2025 for computer vision, Jennis in January 2026 for hormone-intelligent IP) deepen both the AI stack and the women's performance franchise.

The business model combines enterprise SaaS subscriptions to the Te@m platform (quote-based, sales-led via a persistent 'Book Demo' CTA), on-site professional services for biomarker testing delivered by Orreco sports scientists, consumer app subscriptions via iOS App Store and Google Play for FitrWoman/FitrCoach, and licensing/royalty revenue (including an NBA SportRadar data licence). Distribution runs through direct enterprise sales augmented by accelerator/league partnership channels (Comcast NBCUniversal SportsTech, MLS Innovation Lab, LMA Technical Partner) and a UK/US footprint in London and Los Angeles. The company has raised approximately $12M+ across rounds since 2015, most recently a $4M Series A extension in December 2025 led by Mark Cuban with Enterprise Ireland participation.

Name

Orreco

Legal name

Orreco Limited

Website

https://orreco.ai

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Orreco is an Irish sports science AI company that sells a modular Bayesian-inference platform — Te@m, @thlete, FitrWoman and computer-vision injury-risk tooling — to elite professional sports teams, Olympic federations, and women's performance programs across 145+ countries.

Ownership category

akta.pro rank

Product category

Sports Performance Analytics Software

NAICS

Custom Computer Programming Services (541511), Sporting and Athletic Goods Manufacturing (33992)

SIC

Sporting & Athletic Goods, Nec (3949)

akta.pro primary industry

Performance Analysis & Video Coaching (HSADAEAG)

Keywords

• Sports performance analytics
• Athlete biomarker monitoring
• AI injury prediction
• Elite team decision support
• Female athlete science

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Enterprise SaaS Subscriptions (Te@m Platform): Recurring subscription access to the modular Orreco Te@m platform (Biomarkers, Motion Signal, Medical Notes, Recovery Lab, Analytics & Reporting, Wellness, Travel, Tr@ce, Tr*AI*n) sold to elite professional sports teams and governing bodies. Licensing-style deployment to high-value elite customers (NBA, NFL, MLB, NHL, EPL, F1, PGA Tour).
2. Professional / Testing Services (Point-of-Care & Venous Biomarker Service): Delivery of biomarker testing services (capillary POC and venous lab analysis) performed on-site by Orreco sports scientists as part of broader client engagements, plus custom research and consulting engagements tied to the 300+ peer-reviewed publication base.
3. Consumer App Subscriptions (FitrWoman / FitrCoach): Direct-to-consumer subscriptions via App Store and Google Play for FitrWoman (female athlete menstrual cycle and performance tracking) and FitrCoach (coach platform).
4. Licensing / Data Rights (NBA SportRadar license): Per the company's 2024–2025 timeline, Orreco agreed an NBA SportRadar data license, indicating licensing/royalty-style revenue streams tied to league data rights.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Core offering

Orreco provides a modular sports science intelligence platform for elite professional sports teams, federations, and athletes that combines biomarker analysis, computer-vision motion tracking, training-load monitoring, and women's cycle-aware performance science into a single AI-driven decision-support system. The Te@m platform is sold to elite teams with quote-based enterprise subscriptions, paired with the @thlete mobile app for athletes and the FitrWoman/FitrCoach sub-brands for female athletes; biomarker testing services (Point-of-Care and Venous) are delivered on-site as part of broader client engagements.

Product overview

Orreco offers a unified, modular sports science intelligence platform for elite teams and athletes, built on a platform-plus-modules architecture and grounded in over 20 years of Olympic-level research. The Te@m Team Performance Platform is the central web-based product that unifies staff workflows, data and AI agents; it is paired with the @thlete mobile app (introduced 2022, upgraded to @thlete 2.0 with Gen AI in 2024) that gives athletes ownership of their own data, and the FitrWoman / FitrCoach sub-brands that provide women's cycle-aware performance support. Customers compose their stack from a library of modules — Biomarkers, Motion Signal, Recovery Lab, Medical Notes, Analytics & Reporting (B.A.R.I.), Women's Performance, Wellness, Travel, Tr@ce, Tr*AI*n and Push Content to Athletes — and back them with the Orreco.AI agentic AI layer that connects biomarker science, training load, medical data and match outputs into a single decision-support system. The portfolio has been expanded through the 2025 acquisition of Data Driven Sports Analytics (DDSA, adding computer vision) and the 2026 acquisition of Jennis (adding hormone-intelligent IP), and historically includes earlier platforms TrackOR (biomarker analytics, 2014) and ZONE (real-time internal load, 2016).

Differentiator

Problem solved

Functional benefit

Brands

• FitrWoman: Female health app for athletes with menstrual cycle tracking and tailored training, nutrition and recovery advice.
• FitrCoach
• @thlete
• Te@m
• Motion Signal
• B.A.R.I.

Products and services

• Te@m Team Performance Platform Centralised modular performance ecosystem unifying internal load, external load, recovery, wellness, and medical data into a single connected dashboard for high-performance teams, powered by Bayesian agentic AI and the first platform to combine computer vision with internal and external load.
• @thlete Athlete App Mobile athlete-facing companion app (@thlete 2.0 with Gen AI) giving athletes ownership of their performance, recovery, readiness and wellness data with a conversational interface for asking questions of their data.
• FitrWoman The first menstrual tracking app for female athletes, backed by 20 years of Olympic-level research; helps athletes train, compete and recover in sync with their menstrual cycle via cycle tracking, hormonal insights and expert nutrition/recovery advice.
• FitrCoach Coaching platform connecting coaches with female athletes to deliver cycle-informed training, nutrition and recovery programmes.
• Biomarkers Module Module providing objective blood biomarkers for real-time decision making, combining non-invasive Point of Care capillary testing (rapid daily readiness) with comprehensive venous lab testing (deep gold-standard analysis).
• Motion Signal Computer-vision movement technology that converts every movement into a live injury risk score, deviation analytics and tailored conditioning stimulus to flag non-contact soft-tissue injury risk.
• Recovery Lab Decision-support module centralising biomarker results, GPS workload, neuromuscular function, wellness questionnaires, sleep and autonomic-nervous-system data to deliver a holistic personalised view of each athlete's recovery status.
• Medical Notes Centralised, searchable injury and illness documentation module supporting HEAP/SOAP notes, multimedia attachments (images, video, voice notes), injury/illness classification, status management and contextual biomarker/performance overlays.
• Analytics & Reporting (B.A.R.I.) Dynamic dashboard and automated-reporting module unifying GPS, force, biomarkers and wellness data, automating daily/weekly/post-game reports and sending smart alerts when athletes cross critical thresholds.
• Orreco Agent (Orreco.AI) AI platform connecting biomarker science, training load, medical data and match outputs into one intelligent agentic decision layer for elite sport, embedding proprietary Bayesian inference models.
• Jennis Women's health and performance platform co-founded by Olympic champion Dame Jessica Ennis-Hill; brings hormone-intelligent IP integrated with Orreco's AI platform, FitrWoman and DDSA computer vision to create a unified women's performance ecosystem.
• Data Driven Sports Analytics (DDSA) Melbourne-based computer vision startup providing visual movement analysis that feeds Motion Signal's AI-led performance platform, integrating GPS wearables, video-based movement analysis and biomarker testing to flag injury risk.
• Wellness Module Subjective questionnaire logs (muscle soreness, stress, fatigue, sleep, mood) with anatomical muscle selection, fed into Recovery Lab and reported via the athlete app.
• Women's Performance Module Module leveraging FitrWoman's menstrual cycle tracking, hormonal health monitoring and physiology-informed insights to individualise training, nutrition and recovery for female athletes.
• Travel Module Module identifying periods of high travel load across the season to contextualise physiological load and recovery decisions.
• @thlete 2.0 (Generative AI Athlete App) Generative-AI upgrade of the @thlete app enabling conversational queries against athlete performance, biomarker, recovery and wellness data.

Quantifiable outcome

• 85% accuracy in Premier League hamstring injury prediction model
• +5 more outcomes

Named customers13 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability16 records

Feature7 records

Scale indicators12 records

Recent moves8 records

Expansion highlights7 records

Emerging players

• Whoop: Whoop is a consumer wearable focused on recovery, sleep and strain metrics that has been expanding into professional sports partnerships. It is an emerging peer in the recovery-monitoring layer that competes with Orreco's @thlete consumer app and Recovery Lab module.
• Oura: Oura Ring is a consumer wearable providing sleep, HRV and readiness data with growing adoption among elite athletes (Orreco itself integrates Oura in its Recovery Lab). It is an emerging peer in the longitudinal recovery/biomarker space that Orreco's consumer products compete with for athlete mindshare.
• InsideTracker: InsideTracker is a biomarker analytics platform translating blood-test results into personalized performance and longevity recommendations. It is an emerging peer in the consumer-facing biomarker analytics space where Orreco's Biomarkers module and FitrCoach overlap, though it targets individuals rather than elite teams.

Broad incumbents

• Biofourmis: Biofourmis is a broader digital health and biomarker analytics platform used in clinical and pharmaceutical settings. It is a broad incumbent in the underlying biomarker monitoring capability Orreco delivers for elite sport, though not focused on the pro-sports vertical.
• Polar: Polar is a long-established heart rate and performance wearable brand with deep penetration in team sport. It is a broad incumbent in the underlying wearable layer that Orreco integrates with via GPS and the Recovery Lab ecosystem.

Direct peers

• Sparta Science: Sparta Science applies force-plate and AI to predict injury risk and readiness for professional sports teams (NBA, NCAA, MLB). It overlaps directly with Orreco's Motion Signal and Recovery Lab injury-prediction capabilities.
• STATSports: STATSports provides GPS-based player tracking and load monitoring used by elite soccer, GAA and NFL teams. It competes directly with Orreco's external load and wearable integrations across similar elite team customers.
• Kitman Labs: Kitman Labs is an athlete intelligence platform serving elite teams (NFL, NBA, EPL, rugby, soccer) with integrated medical, performance and injury analytics. It is a direct competitor to Orreco's Medical Notes, Recovery Lab and B.A.R.I. modules.
• KinaTrax: KinaTrax provides markerless computer-vision and 3D biomechanical analysis used in MLB and NCAA. It is a direct peer in the computer-vision motion-analysis layer that Orreco's Motion Signal (now augmented by DDSA) competes against.
• Catapult Sports: Catapult is the dominant GPS and athlete monitoring platform in elite pro sport (Soccer, NFL, NBA, EPL). It is the most directly comparable competitor to Orreco's Te@m platform, overlapping on load monitoring, injury risk and team analytics, though historically more focused on hardware-derived GPS than biomarker and computer vision.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ORRECO1
• Facebookfacebook.com/301059349964410
• LinkedInlinkedin.com/company/orreco

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries2 records

Funding overview

Funding rounds6 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Orreco